Art

J-GLOBAL ID：201902261961249738   Reference number：19A0961621

Randomized Phase 2 study of Nintedanib with or without Pirfenidone in IPF patients who experienced FVC decline during prior pirfenidone administration

ピルフェニドンの事前投与中にFVC低下を経験したIPF患者におけるピルフェリドン併用または非併用ニンテダニブのランダム化第二相試験

Author (15)： IKEDA Satoshi (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  SEKINE Akimasa (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  BABA Tomohisa (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  KATANO Takuma (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  MATAMA Goshi (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  AIKO Naoto (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  ISOMOTO Kohsuke (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  OTOSHI Ryota (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  TABATA Erina (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  SHINTANI Ryota (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  NIWA Takashi (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  ODA Tsuneyuki (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  OKUDA Ryo (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  KITAMURA Hideya (Kanagawa Cardiovascular and Respiratory Center, JPN) ,  OGURA Takashi (Kanagawa Cardiovascular and Respiratory Center, JPN)
Material： 日本呼吸器学会誌(Web)  (Annals of the Japanese Respiratory Society (Web))
Volume： 8  Issue： 増刊号(冊子)  Page： 372  Publication year： Mar. 10, 2019 
JST Material Number： U1489A  ISSN： 2186-5884  Document type： Article
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Body text partially displayed： ...[Body text partially displayed]

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Idiopathic Pulmonary Fibrosis

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0961621&from=J-GLOBAL&jstjournalNo=U1489A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J)

Substance index (2)： Nintedanib ,  Pirfenidone

Terms in the title (9)： ピルフェニドン ,  投与 ,  経験 ,  IPF ,  患者 ,  併用 ,  ニンテダニブ ,  ランダム化 ,  第二相試験